Life cycle assessment of multi-step rufinamide synthesis – from isolated reactions in batch to continuous microreactor networks

Abstract

Rufinamide is an antiepileptic drug to treat Lennox–Gastaut syndrome, in combination with other medications. Herein, several batch and continuous process routes to rufinamide are analysed and optimised regarding their environmental impact, to finally predict a fully continuous, telescoped process route.